167 related articles for article (PubMed ID: 28910858)
1. Overview of Methods and Strategies for Conducting Virtual Small Molecule Screening.
Fradera X; Babaoglu K
Curr Protoc Chem Biol; 2017 Sep; 9(3):196-212. PubMed ID: 28910858
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening of compound libraries.
Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
[TBL] [Abstract][Full Text] [Related]
3. Practices in Molecular Docking and Structure-Based Virtual Screening.
Dos Santos RN; Ferreira LG; Andricopulo AD
Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
[TBL] [Abstract][Full Text] [Related]
4. Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.
Vázquez J; López M; Gibert E; Herrero E; Luque FJ
Molecules; 2020 Oct; 25(20):. PubMed ID: 33076254
[TBL] [Abstract][Full Text] [Related]
5. Ligand efficiency based approach for efficient virtual screening of compound libraries.
Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening Techniques in Drug Discovery: Review and Recent Applications.
da Silva Rocha SFL; Olanda CG; Fokoue HH; Sant'Anna CMR
Curr Top Med Chem; 2019; 19(19):1751-1767. PubMed ID: 31418662
[TBL] [Abstract][Full Text] [Related]
7. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
9. Design of screening collections for successful fragment-based lead discovery.
Na J; Hu Q
Methods Mol Biol; 2011; 685():219-40. PubMed ID: 20981526
[TBL] [Abstract][Full Text] [Related]
10. How to Prepare a Compound Collection Prior to Virtual Screening.
Bologa CG; Ursu O; Oprea TI
Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
12. High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery.
Tripathi NM; Bandyopadhyay A
Eur J Med Chem; 2022 Dec; 243():114766. PubMed ID: 36122548
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
14. Automated Inference of Chemical Discriminants of Biological Activity.
Raschka S; Scott AM; Huertas M; Li W; Kuhn LA
Methods Mol Biol; 2018; 1762():307-338. PubMed ID: 29594779
[TBL] [Abstract][Full Text] [Related]
15. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
[TBL] [Abstract][Full Text] [Related]
16. Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening.
Floresta G; Crocetti L; Giovannoni MP; Biagini P; Cilibrizzi A
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1137-1144. PubMed ID: 32367744
[TBL] [Abstract][Full Text] [Related]
17. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
Ebalunode JO; Zheng W; Tropsha A
Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
[TBL] [Abstract][Full Text] [Related]
18. Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.
Pérez GM; Salomón LA; Montero-Cabrera LA; de la Vega JM; Mascini M
Mol Divers; 2016 May; 20(2):421-38. PubMed ID: 26553204
[TBL] [Abstract][Full Text] [Related]
19. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
Stork C; Kirchmair J
Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
[No Abstract] [Full Text] [Related]
20. Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.
Qing XY; Zhang CH; Li LL; Ji P; Ma S; Wan HL; Wang ZR; Zou J; Yang SY
J Biomol Struct Dyn; 2013; 31(2):215-23. PubMed ID: 22831459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
